The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna ...

The Big Three PBMs have largely criticized the FTC report. A spokesperson for CVS Health argued that the FTC has drawn broad conclusions from “cherry-picked” specialty generic outliers in both ...

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth ... in “excess” revenue over six years, the Federal Trade Commission said in a report on the drug middlemen.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

CVS notified Susan Fracasso, rapid response coordinator for the state Department of Labor and Hartford Mayor Arunan ...

CVS just launched a new iPhone app, where it’s trialing a feature that lets you unlock in-store product cabinets with your ...

Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...